Session I: EGFR

Moderator(s)

• 

  Corey Langer, MD, FACP

  Abramson Cancer Center, Hospital of the University of Pennsylvania

Presenter(s)

• 

  Helen Ross, MD

  Banner MD Anderson Cancer Center
• 

  Alexander Spira, MD, PhD, FACP

  Virginia Cancer Specialists, NEXT Oncology Virginia, US Oncology Research
• 

  Helena Yu, MD

  Memorial Sloan Kettering Cancer Center

Presentations:

• 8:00 AM – 8:15 AM

  Welcome and Introduction; Pre-Session Audience Survey
  

  Chair: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
• 8:15 AM – 8:35 AM

  Tissue vs Liquid vs Both: The Holy Grail of Diagnostics
  

  Speaker: Helen J. Ross, MD – Banner MD Anderson Cancer Center
• 8:35 AM – 8:55 AM

  EGFR: 1st Line, Second Line and Beyond in the Age of Osimertinib
  

  Speaker: Helena Yu, MD – Memorial Sloan Kettering Cancer Center
• 8:55 AM – 9:10 AM

  Exon 20 Mutations (the Other EGFR Target)
  

  Speaker: Alexander Spira, MD, PhD, FACP – Virginia Cancer Specialists, NEXT Oncology Virginia, US Oncology Research
• 9:10 AM – 9:20 AM

  Exporting EGFR TKIs to the Curative Setting
  

  Speaker: Helena Yu, MD – Memorial Sloan Kettering Cancer Center
• 9:20 AM – 9:40 AM

  Q&A; Post-Session Audience Survey
  

  Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

  Panelist: Edward B. Garon, MD, MS – University of California, Los Angeles

  Panelist: Helen J. Ross, MD – Banner MD Anderson Cancer Center

  Panelist: Alexander Spira, MD, PhD, FACP – Virginia Cancer Specialists, NEXT Oncology Virginia, US Oncology Research

  Panelist: Helena Yu, MD – Memorial Sloan Kettering Cancer Center